Cambridge Associates Increases Portfolio Holdings in Q2 2026

Cambridge Associates' portfolio saw significant changes during the second quarter of 2026, marked by substantial increases and decreases in specific holdings.

By Insiderset.Aug 17, 2026, 7:19 PM
Cambridge Associates Increases Portfolio Holdings in Q2 2026

Cambridge Associates LLC's portfolio underwent notable adjustments during the period ending June 30, 2026. The firm managed a total portfolio value of $6.88 billion as of that date.

Purchase Activity

Cambridge Associates demonstrated active buying in several sectors this quarter:

  • VUG, the Vanguard U.S. Growth ETF, saw its share count increase by a staggering 504.4%. This significant stake acquisition suggests strong confidence in the growth potential of certain US stocks.
  • IDEV, the iShares Core Dividend Yield ETF, experienced a substantial 61.37% increase in shares held by Cambridge Associates.
  • BSV, Vanguard's BSV fund (likely tracking US Small Cap Value), also showed significant buying with a 102.65% share increase during the quarter.
  • Other notable purchases included RSP, which gained shares, and AOK, another ETF that saw share growth.

    Sale Activity

    Conversely, Cambridge Associates reduced its position in one holding:

    • ESGV, the Vanguard World ex-US Small Cap ETF, experienced a significant reduction with shares decreasing by -52.31%. This indicates Cambridge's decision to exit this particular holding.

      Overall Portfolio Changes

      The changes observed in these holdings reflect Cambridge Associates' dynamic investment strategy for the second quarter of 2026. The firm appears focused on capitalizing on specific market opportunities while strategically divesting from others perceived as less aligned with current objectives.

Cambridge Associates Increases Portfolio Holdings in Q2 2026 | InsiderSet